Imatinib mesylate presents a cytostatic effect on B16 cells in vitro and an apoptotic outcome in melanoma in vivo

Original language	English
DOIs	https://doi.org/10.1096/fasebj.23.1_supplement.625.14
Publication status	Published - Apr 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

• 

Access to Document

• 10.1096/fasebj.23.1_supplement.625.14

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

Pirraco, A., Coelho, P., Rocha, A., Costa, R., & Soares, R. (2009). Imatinib mesylate presents a cytostatic effect on B16 cells in vitro and an apoptotic outcome in melanoma in vivo. https://doi.org/10.1096/fasebj.23.1_supplement.625.14

Pirraco, Ana ; Coelho, Pedro ; Rocha, Ana et al. / Imatinib mesylate presents a cytostatic effect on B16 cells in vitro and an apoptotic outcome in melanoma in vivo.

@conference{1f9d416497584b708271604e37b11bfe,

title = "Imatinib mesylate presents a cytostatic effect on B16 cells in vitro and an apoptotic outcome in melanoma in vivo",

author = "Ana Pirraco and Pedro Coelho and Ana Rocha and Raquel Costa and Raquel Soares",

year = "2009",

month = apr,

doi = "10.1096/fasebj.23.1_supplement.625.14",

language = "English",

}

Pirraco, A, Coelho, P, Rocha, A, Costa, R & Soares, R 2009, 'Imatinib mesylate presents a cytostatic effect on B16 cells in vitro and an apoptotic outcome in melanoma in vivo'. https://doi.org/10.1096/fasebj.23.1_supplement.625.14

Imatinib mesylate presents a cytostatic effect on B16 cells in vitro and an apoptotic outcome in melanoma in vivo. / Pirraco, Ana; Coelho, Pedro; Rocha, Ana et al.
2009.

Research output: Contribution to conference › Abstract › peer-review

TY - CONF

T1 - Imatinib mesylate presents a cytostatic effect on B16 cells in vitro and an apoptotic outcome in melanoma in vivo

AU - Pirraco, Ana

AU - Coelho, Pedro

AU - Rocha, Ana

AU - Costa, Raquel

AU - Soares, Raquel

PY - 2009/4

Y1 - 2009/4

U2 - 10.1096/fasebj.23.1_supplement.625.14

DO - 10.1096/fasebj.23.1_supplement.625.14

M3 - Abstract

ER -

Pirraco A, Coelho P, Rocha A, Costa R, Soares R. Imatinib mesylate presents a cytostatic effect on B16 cells in vitro and an apoptotic outcome in melanoma in vivo. 2009. doi: 10.1096/fasebj.23.1_supplement.625.14